Loading...

LONGEVITY HEALTH HOLDINGS INC Company Mergers 8-K Filing

LNGV

LONGEVITY HEALTH HOLDINGS INC

()

2025 8-K

Summary

Summary

Nasdaq Delisting

Merger of Equals

Merger of Equals

Asset Acquisitions

Merger of Equals

Merger of Equals

Reverse Stock Split

Merger Agreement

Delisting Notice

Asset Acquisition

Stockholder Meeting

Asset Acquisition

Asset Acquisition

Securities Agreement

Investor Presentation

Nasdaq Compliance Notice

Nasdaq Compliance Notice

Management Change

Annual Meeting of Stockholders

Securities Purchase Agreement

Completion of Asset Sale

Agreement for Sale of AxoBio

Management Change

Management Appointment

Management Appointment

Management Appointment

Management Addition

Management Appointment

Management Appointment

Appointment of CEO

Appointment of Directors

Acquisition of Axolotl Biol...

Acquisition Completion

Merger Agreement

Asset Acquisitions

Acquisition Announcement

Investor Notification

Business Combination Agreement

External Links:

Longevity Health Holdings, Inc. amended its merger agreement with 20/20 Biolabs on June 24, 2025, extending the due diligence deadline to July 8, 2025. This merger involves the company merging with its subsidiary, Longevity Health Biomarkers, Inc., and is contingent on specified conditions being met.

AI Assistant

LONGEVITY HEALTH HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.